| Children 0–19 years of ageFever > 3 days | F/ 9 yearsFever for 7 days | F/8 yearsFever for 5 days |
| AND two of the following:1. Rash or conjunctivitis or mucocutaneous inflammation signs2. Shock or hypotension3. Features of myocardial dysfunction, valvulitis, pericarditis, and coronary abnormalities (elevated Troponin/NT-proBNP or ECHO findings)4. Evidence of coagulopathy (by PT, PTT, d-Dimers)5. Acute gastrointestinal problems (diarrhea, vomiting, abdominal pain) | 1. Truncal rash, conjunctivitis, hand/feet swelling3. NT-proBNP ↑, LV function↓ (EF 43%)4. PT prolongation5. Abdominal pain, vomiting | 3. LV function↓ (EF 43%) troponin/NT-proBNP ↑ |
| AND elevated markers of inflammation (ESR, CRP, procalcitonin) | CRP 46.6 mg/L procalcitonin 0.52 ng/mL | (–) |
| ANDNo other obvious microbial cause of inflammation | Mycoplasma Ab (+)Rhinovirus (+)Metapneumovirus (+) | (–) |
| AND evidence of COVID-19 (antigen test, serology or RT-PCR +) or contact with patients with COVID-19. | SARS-CoV-2 Ab (+) | RT-PCR (+)SARS-CoV-2 Ab (+) |
| Shares common features with other pediatric inflammatory conditions including: KD, TSS, bacterial sepsis, MAS | Kawasaki disease | Kawasaki disease |
| Diagnosis | MIS-C | MIS-C,Infective endocarditisInfective myocarditis |
| Management | 1. IVIG 60 g IVF (5/14)2. Aspirin 80 mg QD (5/15-)3. IV methylprednisolone 20 mg q12 hr (5/16–5/19) | 1. Antiviral, Antibiotics2. Methyprednosolone3. IVIG4. Aspirin, Heparin, warfarin5. ACE inhibitor, beta-blocker6. Iron replacement |